NO178370C - Fysikalsk form av (R)-3-metoksy-4-[1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)-indol-3-ylmetylÅ-N-(2-metylfenyl-sulfonyl)benzamid, fremgangsmåte for fremstilling derav og preparat inneholdende denne form - Google Patents

Fysikalsk form av (R)-3-metoksy-4-[1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)-indol-3-ylmetylÅ-N-(2-metylfenyl-sulfonyl)benzamid, fremgangsmåte for fremstilling derav og preparat inneholdende denne form

Info

Publication number
NO178370C
NO178370C NO923467A NO923467A NO178370C NO 178370 C NO178370 C NO 178370C NO 923467 A NO923467 A NO 923467A NO 923467 A NO923467 A NO 923467A NO 178370 C NO178370 C NO 178370C
Authority
NO
Norway
Prior art keywords
methyl
trifluorobutylcarbamoyl
methoxy
benzamide
ylmethyla
Prior art date
Application number
NO923467A
Other languages
English (en)
Norwegian (no)
Other versions
NO178370B (no
NO923467D0 (no
NO923467L (no
Inventor
Murray Watson Cuthbert
Original Assignee
Zeneca Ltd
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd, Ici Plc filed Critical Zeneca Ltd
Publication of NO923467D0 publication Critical patent/NO923467D0/no
Publication of NO923467L publication Critical patent/NO923467L/no
Publication of NO178370B publication Critical patent/NO178370B/no
Publication of NO178370C publication Critical patent/NO178370C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO923467A 1991-09-05 1992-09-04 Fysikalsk form av (R)-3-metoksy-4-[1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)-indol-3-ylmetylÅ-N-(2-metylfenyl-sulfonyl)benzamid, fremgangsmåte for fremstilling derav og preparat inneholdende denne form NO178370C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119001A GB9119001D0 (en) 1991-09-05 1991-09-05 Pharmaceutical agents

Publications (4)

Publication Number Publication Date
NO923467D0 NO923467D0 (no) 1992-09-04
NO923467L NO923467L (no) 1993-03-08
NO178370B NO178370B (no) 1995-12-04
NO178370C true NO178370C (no) 1996-03-13

Family

ID=10700953

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923467A NO178370C (no) 1991-09-05 1992-09-04 Fysikalsk form av (R)-3-metoksy-4-[1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)-indol-3-ylmetylÅ-N-(2-metylfenyl-sulfonyl)benzamid, fremgangsmåte for fremstilling derav og preparat inneholdende denne form

Country Status (21)

Country Link
US (2) US5352694A (fr)
EP (1) EP0531078B1 (fr)
JP (1) JP2914414B2 (fr)
KR (1) KR100254710B1 (fr)
AT (1) ATE138910T1 (fr)
AU (1) AU646587B2 (fr)
CA (1) CA2076722A1 (fr)
CZ (1) CZ281999B6 (fr)
DE (1) DE69211258T2 (fr)
DK (1) DK0531078T3 (fr)
FI (1) FI102372B1 (fr)
GB (2) GB9119001D0 (fr)
HK (1) HK18297A (fr)
HU (2) HU213410B (fr)
IL (1) IL102856A (fr)
NO (1) NO178370C (fr)
NZ (1) NZ244016A (fr)
RU (1) RU2095348C1 (fr)
SK (1) SK279657B6 (fr)
TW (1) TW302359B (fr)
ZA (1) ZA926374B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958780A (en) 1997-06-30 1999-09-28 Boston Advanced Technologies, Inc. Method for marking and identifying liquids
US6149914A (en) * 1999-07-12 2000-11-21 Patel; Jitendra Rambhai Asthma treatment
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
ATE481968T1 (de) 2004-07-14 2010-10-15 Inflammation Res Ct Company Lt Verfahren zur hemmung von tumormetastasierung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524152A (en) * 1982-12-30 1985-06-18 Pennwalt Corporation 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process
GB9026427D0 (en) * 1990-12-05 1991-01-23 Ici Plc Chemical process
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
GB9119001D0 (en) 1991-10-23
AU646587B2 (en) 1994-02-24
NO178370B (no) 1995-12-04
ATE138910T1 (de) 1996-06-15
HU9202660D0 (en) 1992-10-28
GB9216774D0 (en) 1992-09-23
DE69211258D1 (de) 1996-07-11
DE69211258T2 (de) 1996-10-02
FI923869A (fi) 1993-03-06
SK267092A3 (en) 1999-02-11
ZA926374B (en) 1993-03-05
CZ267092A3 (en) 1993-03-17
SK279657B6 (sk) 1999-02-11
JP2914414B2 (ja) 1999-06-28
EP0531078B1 (fr) 1996-06-05
NO923467D0 (no) 1992-09-04
IL102856A (en) 1996-12-05
NZ244016A (en) 1995-01-27
RU2095348C1 (ru) 1997-11-10
US5466826A (en) 1995-11-14
US5352694A (en) 1994-10-04
AU2101292A (en) 1993-03-11
HU213410B (en) 1997-06-30
CZ281999B6 (cs) 1997-04-16
CA2076722A1 (fr) 1993-03-06
HU210879A9 (en) 1995-09-28
FI923869A0 (fi) 1992-08-28
TW302359B (fr) 1997-04-11
HK18297A (en) 1997-02-13
HUT69696A (en) 1995-09-28
EP0531078A1 (fr) 1993-03-10
NO923467L (no) 1993-03-08
KR930005976A (ko) 1993-04-20
FI102372B (fi) 1998-11-30
KR100254710B1 (ko) 2000-05-01
IL102856A0 (en) 1993-01-31
DK0531078T3 (da) 1996-10-14
JPH05194385A (ja) 1993-08-03
FI102372B1 (fi) 1998-11-30

Similar Documents

Publication Publication Date Title
AU683442B2 (en) Aminoacid derivates, medicaments containing these compounds and process for preparing the same
HUT58322A (en) Process for producing new n-(3-hydroxy-4-piperidinyl)-dihydro-benzofurane-, -dihydro-2h-penzopyrane- and -dihydro-benzodioxine-carboxamide derivatives and pharmaceutical compositions containing them
ES8609303A1 (es) Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico
HUT48589A (en) Process for production of new derivatives of substituated n-/1-hydroxi-4-piperidinil/-benzamid
HU903961D0 (en) Process for producing 11-beta-aryl-4-oestrenes and pharmaceutical preparatives containing these compounds
FI894899A0 (fi) Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi
NO178370C (no) Fysikalsk form av (R)-3-metoksy-4-[1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)-indol-3-ylmetylÅ-N-(2-metylfenyl-sulfonyl)benzamid, fremgangsmåte for fremstilling derav og preparat inneholdende denne form
CA2205573A1 (fr) Benzamide peristaltique
HUT61968A (en) Process for producing 2-hydroxy-2-phenylethyl amino compounds and pharmaceutical compositions comprising such active ingredient
AU7266291A (en) A novel substituted-amine compound and a process for the preparation thereof
DE3261625D1 (en) Tricyclic thiazolyl oxamic acids and derivatives, process for their production, and therapeutic agents containing them
IL91986A0 (en) 2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid,derivatives thereof and related compounds,process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
HUT55033A (en) Process for producing aminooligohydroxy derivatives and pharmaceutical compositions comprising same
GB2127014A (en) A compound with analgesic and anti-inflammatory activity, a process for producing same and related pharmaceutical compositions
JPS5239656A (en) Process for preparing novel cyclopropylmethylamine derivatives
CA2622808C (fr) Modification de la forme cristalline d'un derive n-phenyl-2-pyrimidineamine, procede de preparation et d'utilisation de ce dernier
TH6975A (th) การใช้ไอซอกซาโซลิโนนเป็นยาที่ว่องไวต่อสมอง
JPS57118572A (en) N-(4-phenyl-2-thiazolyl)amide derivative, its preparation, and drug composition comprising it
TH6975EX (th) การใช้ไอซอกซาโซลิโนนเป็นยาที่ว่องไวต่อสมอง

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees